€21.03
0.36%
Xetra, Apr 17, 05:35 pm CET
ISIN
DE000BAY0017
Symbol
BAYN
Sector
Industry

Bayer Stock price

€21.03
-2.76 11.60% 1M
-5.47 20.64% 6M
+1.72 8.88% YTD
-5.22 19.89% 1Y
-46.27 68.75% 3Y
-37.54 64.09% 5Y
-112.47 84.25% 10Y
Xetra, Closing price Thu, Apr 17 2025
+0.08 0.36%
ISIN
DE000BAY0017
Symbol
BAYN
Sector
Industry

Key metrics

Market capitalization €20.66b
Enterprise Value €53.45b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 17.20
EV/Sales (TTM) EV/Sales 1.15
P/S ratio (TTM) P/S ratio 0.44
P/B ratio (TTM) P/B ratio 0.65
Dividend yield 0.52%
Last dividend (FY24) €0.11
Revenue growth (TTM) Revenue growth -2.16%
Revenue (TTM) Revenue €46.61b
EBIT (operating result TTM) EBIT €4.52b
Free Cash Flow (TTM) Free Cash Flow €3.11b
Cash position €8.09b
EPS (TTM) EPS €-2.60
P/E forward 10.50
P/S forward 0.45
EV/Sales forward 1.15
Show more

Create a Free Account to create an Bayer alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

Bayer Stock Analysis

Unlock Scores for Free

Analyst Opinions

21 Analysts have issued a Bayer forecast:

6x Buy
29%
15x Hold
71%

Analyst Opinions

21 Analysts have issued a Bayer forecast:

Buy
29%
Hold
71%

Financial data from Bayer

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
46,606 46,606
2% 2%
100%
- Direct Costs 21,270 21,270
8% 8%
46%
25,336 25,336
9% 9%
54%
- Selling and Administrative Expenses 10,561 10,561
2% 2%
23%
- Research and Development Expense 6,209 6,209
16% 16%
13%
8,566 8,566
29% 29%
18%
- Depreciation and Amortization 4,050 4,050
3% 3%
9%
EBIT (Operating Income) EBIT 4,516 4,516
45% 45%
10%
Net Profit -2,552 -2,552
13% 13%
-5%

In millions EUR.

Don't miss a Thing! We will send you all news about Bayer directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Bayer Stock News

Neutral
Reuters
4 days ago
Bayer is lobbying U.S. states to adjust their regulatory framework in its battle to wind down costly litigation over its weedkiller glyphosate, the German chemicals company's CEO said in a draft speech released on Thursday.
Neutral
Business Wire
5 days ago
MYERSTOWN, Pa.--(BUSINESS WIRE)--Today, Bayer proudly celebrated the grand opening of its new 70,000 square foot expansion at its Myerstown facility, following a $44 million investment in 2022. This state-of-the-art facility is a testament to Bayer's commitment to providing trusted self-care solutions to consumers across North America while advancing meaningful engagement with the local communi...
Neutral
Business Wire
5 days ago
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer to Unveil Latest NUBEQA® (darolutamide) Data and Prostate Cancer Research at American Urological Association (AUA) 2025 Annual Meeting.
More Bayer News

Company Profile

Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment engages in the development, production and marketing of prescription products for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology and ophthalmology; diagnostic imaging equipment and the necessary contrast agents. The Consumer Health segment manufactures and markets products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories. The CropScience segment includes seeds and plant traits, crop protection and nonagricultural pest control. The Animal Health segment offers prescription and nonprescription veterinary products. The Covestro segment provides raw materials for polyurethanes; polycarbonate granules and sheets; raw materials for coatings, adhesives and sealants; and by-products of polyether production and of chlorine production and use. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.

Head office Germany
CEO William Anderson
Employees 92,815
Founded 1863
Website www.bayer.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today